Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-11-29
1997-06-24
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
435 691, 435 694, A61K 4700, A61K 31685, A61F 200
Patent
active
056417497
ABSTRACT:
The present invention relates generally to methods for treating injury or degeneration of retinal ganglion cells by administering glial cell line-derived neurotrophic factor (GDNF). The invention relates specifically to methods for treating optic nerve injury or degeneration associated with glaucoma.
REFERENCES:
patent: 3981303 (1976-09-01), Higuchi et al.
patent: 3986510 (1976-10-01), Higuchi et al.
patent: 3995635 (1976-12-01), Higuchi et al.
patent: 4188373 (1980-02-01), Krezanosk
patent: 4217898 (1980-08-01), Theeuwes
patent: 4474452 (1984-10-01), Haslaai
patent: 4474751 (1984-10-01), Haslam et al.
patent: 4474752 (1984-10-01), Haslam et al.
patent: 4518584 (1985-05-01), Mark et al.
patent: 4533234 (1985-08-01), Wong
patent: 4853224 (1989-08-01), Wong
patent: 4863457 (1989-09-01), Lee
patent: 4865846 (1989-09-01), Kaufman
patent: 4882150 (1989-11-01), Kaufman
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5106627 (1992-04-01), Aebischer et al.
patent: 5221696 (1993-06-01), Ke et al.
patent: 5252714 (1993-10-01), Harris et al.
patent: 5384333 (1995-01-01), Davis et al.
patent: 5422116 (1995-06-01), Yen et al.
Malik et al., "TGF-13 Superfamily Members promote Survival of Midgrain Depaminergic Neurons and Protect Them Against MPP+ Toxicity", EMSO Journal, vol. 14 (4) pp. 736-742 (1995).
M. S. Silverman and E. S. Hughes, "Tranplantation of Photoreceptors to Light Damaged Retinas", Investigative Opthamology and Visual Science, vol. 3/8, Aug., pp. 1684-1690 (1989).
Aebischer et al. (1991), `Long-Term Cross-Species Brain Transplantation of a Polymer-Encapsulated Dopamine-Secreting Cell Line`, Exper. Neurol. 111:269-275.
Beck et al. (1995), `Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain`, Nature 373:339-341.
Bothwell (1995), `Functional Interactions of Neurotrophins and Neurotrophin Receptors`, Ann., Rev. Neurosci. 18:223-253.
Chamow et al. (1994), `Modification of CD4 Immunoadhesin with Monomethoxypoly (ethylene glycol) Aldehyde via Reductive Alkylation`, Bioconjugate Chem. 5:133-140.
Chao et al. (1995) `p75 and Trk: a two-receptor system`, TINS 18:321-326.
Cunningham and Wells (1989), `High-Resolution Epitope Mapping of hGH-Receptor Interactions by Alanine-Scanning Mutagenesis`, Science 244:1081-1085.
Dayhoff (1972), Atlas of Protein Sequence and Structure 5:124.
Francis (1992), `Protein modification and fusion proteins`, Focus on Growth Factors 3(2):4-10.
Gurny, R. et al. (1987), `Design and Evaluation of Controlled Release Systems For The Eye`, Journal of Controlled Release 6:367-373.
Hefti (1994), `Neurotrophic Factor Therapy for Nervous Sytem Degenerative Diseases`, J. Neurobiol. 25:1418-1435.
Henderson et al. (1994), `GDNF: A Potent Survival Factor for Motoneurons Present in Peripheral Nerve and Muscle`, Science 266:1062-1064.
Hoffer et al. (1994), `Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo`, Neurosci. Lett. 182:107-111.
Hudson et al. (1995), `Glial Cell Line-derived Neurotrophic Factor Augments Midbrain Dopaminergic Circuits In Vivo`, Brain Res. Bull. 36:425-432.
Kastner et al. (1994), `Glial cell-line derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats`, Mol. Brain Res. 26:325-330.
Krieglstein et al. (1995), `TGF-.beta. superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity`, EMBO J. 14:736-742.
Lehwalder et al. (1989), `Rapid Communication Survival of Purified Embryonic Chick Retinal Ganglion Cells in the Presence of Neurotrophic Factors`, J. Neurosci. Res. 24:329-337.
Leifer et al. (1991), `Brief Communication Immunofluorescent Characterization of Retinal Ganglion Cell Neurites Cultures on Substrates Coated with Antibodies against Thy-1`, Exp. Neurol. 113:386-390.
Lin et al. (1993), `GDNF: A Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons`, Science 260:1130-1132.
Louis et al. (1992), `Receptor-Mediated Toxicity of Norepinephrine on Cultured Catecholaminergic Neurons of the Rat Brain Stem.sup.1 `, J. Pharmacol. Exp. Therap. 262:1274-1283.
Louis et al. (1993), `CNTF Protection of Oligodendrocytes Against Natural and Tumor Necrosis Factor-Induced Death`, Science 259:689-692.
Malik et al. (1992), `Polyethylene Glycol (PEG)-modified Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) with Conserved Biological Activity`, Exp. Hematol. 20:1028-1035.
Mansour-Robaey et al. (1994), `Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells`, Proc. Natl. Acad. Sci 91:1632-1636.
Matheson et al. (1995), `The In Vivo Responses of Neonatal Rat Dorsal Root Ganglion Neurons to Neurotrophins and GDNF`, Soc. Neurosci. Abstr. 21:544.
Oppenheim et al. (1995), `Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF`, Nature 373:344-346.
Poulsen et al. (1994), `TGF.beta.2 and TGF.beta.3 Are Potent Survival Factors for Midbrain Dopaminergic Neurons`, Neuron 13:1245-1252.
Schaar et al. (1994), `Multiple Astrocyte Transcripts Encode Nigral Trophic Factors in Rat and Human`, Exp. Neurol. 130:387-393.
Schaar et al. (1993), `Regional and Cell-Specific Expression of GDNF in Rat Brain`, Exp. Neurol. 124:368-371.
Snider (1994), `Functions of the Neurotrophins during Nervous System Development: What the Knockouts Are Teaching Us`, Cell 77:627-638.
Theonen et al. (1985), `Neurotrophic Factors`, Science 229:238-242.
Thoenen (1991), `The changing scene of neurotrophic factors`, Trends. Neurosci. 14:165-170.
Tomac et al. (1995), `Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo`, Nature 373:335-339.
Tresco et al. (1992), `Polymer Encapsulated Neurotransmitter Secreting Cells`, ASAIO 38:17-23.
Trupp et al. (1995), `Peripheral Expression and Biological Activities of GDNF, a New Neurotrophic Factor for Avian and Mammalian Peripheral Neurons`, J. Cell Biol. 130:137-148.
Varon et al. (1978), `Trophic Mechanisms in the Peripheral Nervous System`, Ann. Rev. Neuroscience 1:327-361.
Winn et al. (1991), `Behavioral Recovery following Intrastriatal Implantation of Microencapsulated PC12 Cells`, Exper. Neurol. 113:322-329.
Yan et al. (1993), `Influences of Neorotrophins on Mammalian Motoneurons in vivo`, J. Neurobiol. 24:1555-77.
Yan and Matheson (1995), `In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons`, Nature 373:341-344.
Zurn et al. (1994), `Glial cell-line derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurones`, Neuroreport 6:113-118.
Louis Jean-Claude
Yan Qiao
Amgen Inc.
Curry Daniel R.
Levy Ron K.
Odre Steven M.
Schain Howard E.
LandOfFree
Method for treating retinal ganglion cell injury using glial cel does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating retinal ganglion cell injury using glial cel, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating retinal ganglion cell injury using glial cel will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-149147